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Thoracic Surgery, West Penn Allegheny Health System,
Pittsburgh, PA
Objectives: According to NKF-DOQI guidelines, bra-
chiobasilic fistulas (bbfs) are the next best alternative if a
radio- or brachio-cephalic fistula cannot be successfully
created. However, there are few current, large series in the
literature examining their outcomes. Our objective was to
review our experience with bbfs, including the factors af-
fecting functional patency.
Methods: We reviewed 134 consecutive bbfs per-
formed over a period of 5 years. We recorded demograph-
ics, comorbidities, time to access, and functional patency.
Data were analyzed by chi-square, life-table, and propor-
tional hazards modeling.
Results: 15 patients were either lost to initial follow up
(n6), died (n8), or received transplant (n1) before
dialysis was attempted. Among the remaining 119, mean
follow-up was 22months. Three bbfs were ligated early due
to steal and 25 failed to mature. 91 bbfs (76%) matured to
successful dialysis. Of these, median time to first access was
6 weeks (mean 6.4 weeks). By life-table analysis, median
functional primary patency was 41 months, while median
primary assisted patency was 49 months. The only signifi-
cant factor predicting increased primary patency was female
gender (figure).
Diabetic patients exhibited a non-significant trend toward
shorter patency. BMI, age, and smoking were not predic-
tors of time to failure.
Conclusions:This large series shows that bbfs can yield
acceptable long-term functional outcomes with maturation
rates higher than those generally reported for forearm
fistulas. The procedure appears to be especially valuable in
females, and outcomes are not adversely affected by ele-
vated age or BMI.
Author Disclosures: D. Healy: Nothing to disclose; S.
Muluk: Nothing to disclose; C. Yossa: Nothing to dis-
close.
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Microvascular Porcine Model for the Optimization of
Composite Tissue AutoTransplantation
Carole Villamaria, Todd Rasmussen, Jerry Spencer,
Michael Davis. US Army Institute of Surgical Research, Ft.
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Introduction: Devastating extremity injuries are prev-
alent on the modern battlefield. Improved body armor,
rapid evacuation times and advanced critical care yield
survivability in the face of catastrophic limb trauma. The
number and complexity of these injuries requires novel
methods for salvage and reconstruction. This model is de-
signed to assess the solution H2S for its ability to optimize
tissue stability and viability during composite tissue transplan-
tation and thus expand reconstruction applications.
Methods: A donor gracilis myocutaneous flap with its
associated Mathes type II arteriovenous axis is procured
from 70-90kg Yorkshire swine. Utilizing the right external
carotid artery and internal jugular vein as the recipient axis,
microvasular anastamosis is performed. Control group 1
undergoes immediate microvascular anastamosis with re-
sultant 1 hour ischemic period with interim perfusion with
heparinized saline. Control group 2 undergoes delayed
anastamosis with 3 hour ischemic period and interim per-
fusion with heparinized saline. These are compared with
experimental group I which undergoes interim perfusion
with H2S for 1 hour and experimental group 2 which
undergoes interim perfusion with H2S for 3 hours. Mark-
ers of ischemia-reperfusion injury are evaluated following
anastamosis and on POD#1, 2, 7 and 14.
Results: This porcine microvascular model has been
validated and control animals accomplished. The standard
degree of ischemia-reperfusion injury has been established
in the controls with laboratory and histologic analysis.
Experimental groups are now underway.
Conclusions: We have established and validated a
novel porcine model for microvascular composite tissue
transplantation. This model will be utilized to assess the
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